Federal award
ORTHO-CLINICAL DIAGNOSTICS, INC
W91YTV08F0200
Contract
Obligated and Ceiling
- Obligated (net)
- $431,394.44
- Ceiling (potential value, not spending)
- $431,394.76
- Current value
- $431,394.76
- Gross positive obligations
- $510,395.43
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- ORTHO-CLINICAL DIAGNOSTICS, INC · JG5JF2JQJ121
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- JOHNSON & JOHNSON HEALTHCARE · LKV3QN1ND7D1
- Awarding agency
- Department of War · sub-agency 2100 · office W81K04
- Funding agency
- Department of War · sub-agency 2100
- Product or service (PSC)
- 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
- Industry (NAICS)
- 325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
- PIID
- W91YTV08F0200
- Parent vehicle (IDV PIID)
- V797P7126A
- Award type code
- C
- Actions
- 11 · Sep 30, 2008 to Sep 15, 2017
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History11
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Sep 15, 2017 | FY2017 | P00012 | K | −$75,979.18 | — |
| Jul 26, 2013 | FY2013 | P00011 | D | $0.00 | — |
| Sep 22, 2012 | FY2012 | P00010 | C | −$2,298.29 | — |
| Sep 6, 2012 | FY2012 | P00009 | G | $125,783.06 | — |
| Aug 24, 2011 | FY2011 | P00008 | G | $127,395.14 | — |
| Aug 3, 2011 | FY2011 | P00007 | M | $62,265.24 | — |
| Sep 8, 2010 | FY2010 | P00006 | G | $65,486.23 | — |
| Sep 29, 2009 | FY2009 | P00003 | C | $754.20 | — |
| Aug 25, 2009 | FY2009 | P00002 | C | $64,355.80 | — |
| Oct 23, 2008 | FY2009 | P00001 | C | −$723.52 | — |
| Sep 30, 2008 | FY2008 | 0 | — | $64,355.76 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.